Next, we tested the effect of reducing free bilirubin by treatment with HSA or HO-1 inhibitor SnPP on cerebellum development and apoptosis in neonatal Ugt1−/− mice, a genetic model of hyperbilirubinemia (15). This evidence concerns the gene HMOX1 and Hyperbilirubinemia.